| Richard P. Eno |
Mr. Richard P. Eno is on the Board of Directors at BioAmber, Inc., Biotechnology Innovation Organization and Telles LLC. Mr. Eno was previously employed as President, Chief Executive Officer & Director by Metabolix, Inc., Vice President by CRA International, Inc., and Vice President by Arthur D. Little, Inc. He received his undergraduate degree from Cornell University and an MBA from the University of Houston. |
| Raymond J. Land |
Mr. Raymond J. Land, CPA, is a Chairman at BioAmber, Inc. and an Independent Director at Anika Therapeutics, Inc. He is on the Board of Directors at Anika Therapeutics, Inc. and Mountain View Pharmaceuticals, Inc. Mr. Land was previously employed as a Chief Financial Officer & Senior Vice President by Clarient, Inc., a Chief Financial Officer & Senior Vice President by Safeguard Scientifics, Inc., a Chief Financial Officer & Executive Vice President by Medcenter Solutions, Inc., a Chief Financial Officer & Senior Vice President by Orchid Cellmark, Inc., a Chief Financial Officer & Senior Vice President by Genencor International, Inc., a Chief Financial Officer & Senior Vice President by The West Co., a General Manager-Frozen Food Division by Campbell Soup Co., and an Audit Manager by Coopers & Lybrand LLP. He received his undergraduate degree from Temple University (Pennsylvania). |
| Ellen B. Richstone |
Ms. Ellen B. Richstone is an Independent Director at Superior Industries International, Inc., an Independent Director at eMagin Corp., an Independent Director at BioAmber, Inc., a Member at Corporate Directors Group and a Member at Women Corporate Directors. She is on the Board of Directors at Orion Energy Systems, Inc., Superior Industries International, Inc., eMagin Corp., BioAmber, Inc., BlueShift Technologies, Inc., Employment Resources, Inc. and National Association of Corporate Directors (New England). Ms. Richstone was previously employed as an Independent Non-Executive Director by Parnell Pharmaceuticals Holdings Ltd., an Independent Director by The Oneida Group, Inc., an Executive Vice President by Luminus Devices, Inc., a Chief Financial Officer by Sonus Networks, Inc. /Old/, a President & Chief Executive Officer by Entrepreneurial Resources Group LLC, a Chief Financial Officer by Rohr Aero Services-Asia Pte Ltd, a Chief Financial Officer by Augat, Inc., a Chief Financial Officer by Brooks Automation, Inc., a Principal by Data General Corp., a Chief Financial Officer by Honeywell Building Solutions, and a Principal by Polaroid Corp. She also served on the board at American Power Conversion Corp. and Financial Executives International. She received her undergraduate degree from Scripps College and a graduate degree from Fletcher School of Law. |
| Kurt W. Briner |
Mr. Kurt W. Briner is Independent Director at BioAmber, Inc. He is on the Board of Directors at BioAmber, Inc. and Vifor Pharma AG.
Mr. Briner was previously employed as Non-Executive Director by Galenica AG, Independent Director by Progenics Pharmaceuticals, Inc., and President & Chief Executive Officer by Sanofi-Aventis SA. He also served on the board at Novo Nordisk A and Galenica SA. |
| Heinz Haller |
Mr. Heinz Haller is an Independent Non-Executive Director at Arbonia AG, an Independent Director at BioAmber, Inc., an Executive Vice President at The Dow Chemical Co., a Chairman at Dow AgroSciences LLC, a Chairman at Dowaksa Advanced Composite Materials Industry Co. Ltd., a Chairman at DowAksa Advanced Composites Holdings BV and a Chief Commercial Officer, EVP & President-EMEA at Dow Europe GmbH. He is on the Board of Directors at Arbonia AG, BioAmber, Inc., Advanced Electrolyte Technologies LLC, Michigan Molecular Institute, South Pole Holding AG and U.S.-India Business Council. Mr. Haller was previously employed as a President by Dow Europe SA, a Lead Director by Dow Corning Corp., a Managing Director by Allianz Capital Partners GmbH, a Chief Executive Officer by Red Bull Sauber Holding AG, a Chief Executive Officer by Sauber Petronas Engineering AG, a Managing Director by Plüss-Staufer AG, and a Chairman by XALT Energy LLC. He also served on the board at Mycogen Corp. and Univation Technologies LLC. He received his MBA from the International Institute for Management Development. |
| Mario Settino |
Mr. Mario Settino is Chief Financial Officer at BioAmber, Inc. He is on the Board of Directors at Imaflex, Inc. Mr. Settino was previously employed as Chief Financial Officer & Head-Investor Relations by Miranda Technologies, Inc., Vice President-Aircraft Finance by Bombardier Aerospace, Inc., and Senior Vice President-Finance by Provigo, Inc. He received his undergraduate degree from Concordia University. |
| James Millis |
Mr. Kurt W. Briner is Independent Director at BioAmber, Inc. He is on the Board of Directors at BioAmber, Inc. and Vifor Pharma AG.
Mr. Briner was previously employed as Non-Executive Director by Galenica AG, Independent Director by Progenics Pharmaceuticals, Inc., and President & Chief Executive Officer by Sanofi-Aventis SA. He also served on the board at Novo Nordisk A and Galenica SA. |
| Thomas Desbiens |
Mr. Thomas Desbiens is General Counsel at BioAmber, Inc. He is on the Board of Directors at BioAmber Sarnia, Inc. Mr. Desbiens was previously employed as Secretary & General Counsel by DNP Green Technology, Inc. He received his graduate degree from the University of Ottawa. |
| Michael A. Hartmann |
Mr. Michael A. Hartmann is a President-BioAmber Sarnia at BioAmber, Inc. and a Treasurer at Andover Canadian Fund, Inc. Mr. Hartmann was previously employed as an Executive Director-Institutional Sales by CIBC World Markets, Inc. He received his undergraduate degree from Rollins College (Florida) and an MBA from York University. |
| Kenneth W. Wall |
Mr. Fabrice Orecchioni is President, Chief Operating & Executive Officer at BioAmber, Inc. He is on the Board of Directors at BioAmber Sarnia, Inc. Mr. Orecchioni was previously employed as Plant Manager by Abengoa Bioenergy France SA and Production Manager by Ajinomoto Foods Europe SAS. He received his undergraduate degree from Université Pierre et Marie Curie, an undergraduate degree from École de Biologie Industrielle and an MBA from École des Hautes Études Commerciales de Paris. |
| Robert Milton Frost |
Mr. Robert M. Frost is Partner at Naxos UK Ltd., Board Observer at Big Red, Inc., Partner at NAXOS Capital Managers SARL, and a Managing Director at Allianz Capital Partners GmbH. He is on the Board of Directors at Revolymer Plc, RecyCoal Ltd., Elevance Renewable Sciences, Inc., Sowams Capital Ltd., and i2O Water Ltd.
He received his MBA from London Business School. |
| Raymond J. Land |
Mr. Fabrice Orecchioni is President, Chief Operating & Executive Officer at BioAmber, Inc. He is on the Board of Directors at BioAmber Sarnia, Inc. Mr. Orecchioni was previously employed as Plant Manager by Abengoa Bioenergy France SA and Production Manager by Ajinomoto Foods Europe SAS. He received his undergraduate degree from Université Pierre et Marie Curie, an undergraduate degree from École de Biologie Industrielle and an MBA from École des Hautes Études Commerciales de Paris. |
| Roy McDowall |
Mr. Roy McDowall is Head-Media & Investor Relations at BioAmber, Inc. |
| Anne Waddell |
Ms. Anne Waddell is Vice President-Government Affairs at BioAmber, Inc. |
